These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11261232)

  • 1. Can 5' nucleotidase estimation be a predictor of liver metastases?
    Rathnakumar G; Raste AS
    Indian J Cancer; 2000 Mar; 37(1):23-6. PubMed ID: 11261232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of 5'nucleotidase in primary and secondary neoplasms of the liver].
    Tozzoli R; Risaliti A; Bacelle L; Perosa A; Formentini V; Bruno G; Calandra A
    Chir Ital; 1988 Apr; 40(2):146-51. PubMed ID: 2458852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaline phosphatase isoenzymes for the diagnosis of metastatic tumors and lymphomas of liver and bone.
    Yorio MA; Sembaj A; Sanz E; Carriazo C; Moreno Barral J
    Medicina (B Aires); 2000; 60(3):311-5. PubMed ID: 11050806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
    Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ
    Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is routine magnetic resonance imaging justified for the early detection of resectable liver metastases from colorectal cancer?
    Titu LV; Breen DJ; Nicholson AA; Hartley J; Monson JR
    Dis Colon Rectum; 2006 Jun; 49(6):810-5. PubMed ID: 16741638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
    Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
    Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: results of a prospective comparative study.
    Singh P; Mukhopadhyay P; Bhatt B; Patel T; Kiss A; Gupta R; Bhat S; Erickson RA
    J Clin Gastroenterol; 2009 Apr; 43(4):367-73. PubMed ID: 18981929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
    Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B
    J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic values of measuring the liver volume in detecting occult hepatic metastases from colorectal cancer.
    Ishizawa T; Yamamoto T; Sekikawa T
    Hepatogastroenterology; 2007 Mar; 54(74):514-7. PubMed ID: 17523310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
    Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
    Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
    Ottó S
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin binding to serum 5'-nucleotidase and alkaline phosphatase in liver disease.
    Massoubre C; Verdier P; Meflah K; Masliah C; Perrin D; Orsonneau JL; Harb J
    Clin Chim Acta; 1990 Oct; 191(1-2):87-92. PubMed ID: 1963578
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
    D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
    Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of 5'-nucleotidase analysis in clinical tests].
    Shibata H
    Nihon Rinsho; 1989 Dec; 48 Suppl():313-5. PubMed ID: 2560078
    [No Abstract]   [Full Text] [Related]  

  • 17. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
    Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
    Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.
    Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J
    Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiofrequency ablation in primary and secondary liver tumors].
    Carditello A; Scisca C; David A; Stilo F; Basile M
    Chir Ital; 2002; 54(1):83-6. PubMed ID: 11942016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.